Cargando…
Management of a Candida Auris Patient Across Two Healthcare Systems
BACKGROUND: Containing Candida auris (C. auris) has proven to be especially challenging during the COVID-19 pandemic given the enormous constraints on Infection Prevention (IP) departments. Knowledge of the organism, appropriate identification methods, and infection prevention strategies are key to...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Mosby, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215281/ http://dx.doi.org/10.1016/j.ajic.2022.03.098 |
_version_ | 1784731176407138304 |
---|---|
author | Halvorson, Amanda J. Dumonceaux, Patricia L. Kiffmeyer, Elizabeth Welle, Tamara M. Ellen, Simonson Ferguson, Joann Hesse, Rebecca |
author_facet | Halvorson, Amanda J. Dumonceaux, Patricia L. Kiffmeyer, Elizabeth Welle, Tamara M. Ellen, Simonson Ferguson, Joann Hesse, Rebecca |
author_sort | Halvorson, Amanda J. |
collection | PubMed |
description | BACKGROUND: Containing Candida auris (C. auris) has proven to be especially challenging during the COVID-19 pandemic given the enormous constraints on Infection Prevention (IP) departments. Knowledge of the organism, appropriate identification methods, and infection prevention strategies are key to reducing the risk of transmission. Many IP departments have been unable to develop or maintain comprehensive admission screening protocols and have limited best practices available for managing C. auris patients in the acute care setting. We describe the first case of C. auris in the acute care setting in the state of Minnesota and outline the infection prevention strategies used by the two systems that provided care to this patient. METHODS: Upon receipt of a preliminary positive C. auris result at Hospital One, the patient was placed into contact precautions. All patients that were identified as exposed were screened. A comprehensive infection prevention strategy was implemented in collaboration with the state health department and Hospital Two. The plan included transmission-based precautions, hand hygiene compliance, environmental cleaning and disinfection, and staff and patient education. RESULTS: A total of 48 patients were screened for C. auris at Hospital One and no additional positive results were identified. The patient was transferred to Hospital Two for progressive care needs and required an extensive hospital stay post-surgery. No additional screening was recommended by the state health department. Practical prevention strategies for high level disinfection and sterilization, environmental cleaning, patient transport and ambulation, and procedural protocols were developed. No additional C. auris colonization nor clinical isolates have been identified to date. CONCLUSIONS: This case highlighted the importance of inter-facility communication and the need for an established screening protocol for C. auris to identify cases in a timely manner. The robust infection prevention strategies implemented by the two systems resulted in no known transmission to other patients or staff. |
format | Online Article Text |
id | pubmed-9215281 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Published by Mosby, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92152812022-06-22 Management of a Candida Auris Patient Across Two Healthcare Systems Halvorson, Amanda J. Dumonceaux, Patricia L. Kiffmeyer, Elizabeth Welle, Tamara M. Ellen, Simonson Ferguson, Joann Hesse, Rebecca Am J Infect Control Ec-51 BACKGROUND: Containing Candida auris (C. auris) has proven to be especially challenging during the COVID-19 pandemic given the enormous constraints on Infection Prevention (IP) departments. Knowledge of the organism, appropriate identification methods, and infection prevention strategies are key to reducing the risk of transmission. Many IP departments have been unable to develop or maintain comprehensive admission screening protocols and have limited best practices available for managing C. auris patients in the acute care setting. We describe the first case of C. auris in the acute care setting in the state of Minnesota and outline the infection prevention strategies used by the two systems that provided care to this patient. METHODS: Upon receipt of a preliminary positive C. auris result at Hospital One, the patient was placed into contact precautions. All patients that were identified as exposed were screened. A comprehensive infection prevention strategy was implemented in collaboration with the state health department and Hospital Two. The plan included transmission-based precautions, hand hygiene compliance, environmental cleaning and disinfection, and staff and patient education. RESULTS: A total of 48 patients were screened for C. auris at Hospital One and no additional positive results were identified. The patient was transferred to Hospital Two for progressive care needs and required an extensive hospital stay post-surgery. No additional screening was recommended by the state health department. Practical prevention strategies for high level disinfection and sterilization, environmental cleaning, patient transport and ambulation, and procedural protocols were developed. No additional C. auris colonization nor clinical isolates have been identified to date. CONCLUSIONS: This case highlighted the importance of inter-facility communication and the need for an established screening protocol for C. auris to identify cases in a timely manner. The robust infection prevention strategies implemented by the two systems resulted in no known transmission to other patients or staff. Published by Mosby, Inc. 2022-07 2022-06-22 /pmc/articles/PMC9215281/ http://dx.doi.org/10.1016/j.ajic.2022.03.098 Text en Copyright © 2022 Published by Mosby, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Ec-51 Halvorson, Amanda J. Dumonceaux, Patricia L. Kiffmeyer, Elizabeth Welle, Tamara M. Ellen, Simonson Ferguson, Joann Hesse, Rebecca Management of a Candida Auris Patient Across Two Healthcare Systems |
title | Management of a Candida Auris Patient Across Two Healthcare Systems |
title_full | Management of a Candida Auris Patient Across Two Healthcare Systems |
title_fullStr | Management of a Candida Auris Patient Across Two Healthcare Systems |
title_full_unstemmed | Management of a Candida Auris Patient Across Two Healthcare Systems |
title_short | Management of a Candida Auris Patient Across Two Healthcare Systems |
title_sort | management of a candida auris patient across two healthcare systems |
topic | Ec-51 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215281/ http://dx.doi.org/10.1016/j.ajic.2022.03.098 |
work_keys_str_mv | AT halvorsonamandaj managementofacandidaaurispatientacrosstwohealthcaresystems AT dumonceauxpatricial managementofacandidaaurispatientacrosstwohealthcaresystems AT kiffmeyerelizabeth managementofacandidaaurispatientacrosstwohealthcaresystems AT welletamaram managementofacandidaaurispatientacrosstwohealthcaresystems AT ellensimonson managementofacandidaaurispatientacrosstwohealthcaresystems AT fergusonjoann managementofacandidaaurispatientacrosstwohealthcaresystems AT hesserebecca managementofacandidaaurispatientacrosstwohealthcaresystems |